对邹的《托法替布治疗难治性白塞病的初步研究》的回复 - Suppr

Response to: 'Correspondence on 'A pilot study of tofacitinib for refractory Behçet's syndrome'' by Zou .

作者信息

Liu Jinjing, Zhao Chan, Zheng Wenjie

机构信息

Department of Rheumatology and Clinical Immunology, Key Laboratory of Rheumatology and Clinical Rheumatology, Ministry of Education, National Clinical Research Center for Dermatologic and Immunologic Diseases, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Department of Ophthalmology, Peking Union Medical College Hospital, Key Laboratory of Ocular Fundus Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

出版信息

Ann Rheum Dis. 2023 Apr;82(4):e101. doi: 10.1136/annrheumdis-2020-219828. Epub 2021 Jan 25.

DOI:10.1136/annrheumdis-2020-219828

PMID:33495151

Abstract

摘要

相似文献

Response to: 'Correspondence on 'A pilot study of tofacitinib for refractory Behçet's syndrome'' by Zou .

Ann Rheum Dis. 2023 Apr;82(4):e101. doi: 10.1136/annrheumdis-2020-219828. Epub 2021 Jan 25.

Correspondence on 'A pilot study of tofacitinib for refractory Behçet's syndrome'.

Ann Rheum Dis. 2023 Apr;82(4):e100. doi: 10.1136/annrheumdis-2020-219810. Epub 2021 Jan 25.

A pilot study of tofacitinib for refractory Behçet's syndrome.

Ann Rheum Dis. 2020 Nov;79(11):1517-1520. doi: 10.1136/annrheumdis-2020-217307. Epub 2020 May 27.

Gastrointestinal: Refractory parastomal ulcers of Behcet's disease responsive to tofacitinib.

J Gastroenterol Hepatol. 2023 Apr;38(4):485. doi: 10.1111/jgh.15997. Epub 2022 Oct 2.

Case report: Refractory intestinal Behçet's syndrome successfully treated with tofacitinib: A report of four cases.

Front Immunol. 2022 Sep 15;13:981502. doi: 10.3389/fimmu.2022.981502. eCollection 2022.

SER recommendations on treatment of refractory Behçet's syndrome.

Reumatol Clin (Engl Ed). 2024 Apr;20(4):204-217. doi: 10.1016/j.reumae.2023.12.006. Epub 2024 Apr 12.

TNF-alpha antagonists and thalidomide for the management of gastrointestinal Behçet's syndrome refractory to the conventional treatment modalities: a case series and review of the literature.

Clin Exp Rheumatol. 2015 Nov-Dec;33(6 Suppl 94):S129-37. Epub 2015 Oct 20.

Management of Behçet's syndrome.

Curr Opin Rheumatol. 2016 Jan;28(1):45-50. doi: 10.1097/BOR.0000000000000231.

Multiple peripheral arterial and aortic aneurysms in Behcet's syndrome: a case report.

Clin Rheumatol. 2008 Feb;27(2):265-7. doi: 10.1007/s10067-007-0713-z. Epub 2007 Oct 11.

Baricitinib for the treatment of refractory vascular Behçet's disease.

Clin Immunol. 2023 May;250:109298. doi: 10.1016/j.clim.2023.109298. Epub 2023 Mar 24.

引用本文的文献

Rise of biologics in noninfectious uveitis: a retrospective cohort study from Nepal.

Ann Med Surg (Lond). 2023 Apr 11;85(5):1486-1489. doi: 10.1097/MS9.0000000000000546. eCollection 2023 May.

Recent Insights into the Management of Behçet Syndrome.

J Inflamm Res. 2021 Jul 20;14:3429-3441. doi: 10.2147/JIR.S285400. eCollection 2021.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Response to: 'Correspondence on 'A pilot study of tofacitinib for refractory Behçet's syndrome'' by Zou .

作者信息

Liu Jinjing, Zhao Chan, Zheng Wenjie

机构信息

Department of Ophthalmology, Peking Union Medical College Hospital, Key Laboratory of Ocular Fundus Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

出版信息

Ann Rheum Dis. 2023 Apr;82(4):e101. doi: 10.1136/annrheumdis-2020-219828. Epub 2021 Jan 25.

DOI:10.1136/annrheumdis-2020-219828

PMID:33495151

Abstract

摘要

相似文献

Response to: 'Correspondence on 'A pilot study of tofacitinib for refractory Behçet's syndrome'' by Zou .

Ann Rheum Dis. 2023 Apr;82(4):e101. doi: 10.1136/annrheumdis-2020-219828. Epub 2021 Jan 25.

Correspondence on 'A pilot study of tofacitinib for refractory Behçet's syndrome'.

Ann Rheum Dis. 2023 Apr;82(4):e100. doi: 10.1136/annrheumdis-2020-219810. Epub 2021 Jan 25.

A pilot study of tofacitinib for refractory Behçet's syndrome.

Ann Rheum Dis. 2020 Nov;79(11):1517-1520. doi: 10.1136/annrheumdis-2020-217307. Epub 2020 May 27.

Gastrointestinal: Refractory parastomal ulcers of Behcet's disease responsive to tofacitinib.

J Gastroenterol Hepatol. 2023 Apr;38(4):485. doi: 10.1111/jgh.15997. Epub 2022 Oct 2.

Case report: Refractory intestinal Behçet's syndrome successfully treated with tofacitinib: A report of four cases.

Front Immunol. 2022 Sep 15;13:981502. doi: 10.3389/fimmu.2022.981502. eCollection 2022.

SER recommendations on treatment of refractory Behçet's syndrome.

Reumatol Clin (Engl Ed). 2024 Apr;20(4):204-217. doi: 10.1016/j.reumae.2023.12.006. Epub 2024 Apr 12.

TNF-alpha antagonists and thalidomide for the management of gastrointestinal Behçet's syndrome refractory to the conventional treatment modalities: a case series and review of the literature.

Clin Exp Rheumatol. 2015 Nov-Dec;33(6 Suppl 94):S129-37. Epub 2015 Oct 20.

Management of Behçet's syndrome.

Curr Opin Rheumatol. 2016 Jan;28(1):45-50. doi: 10.1097/BOR.0000000000000231.

Multiple peripheral arterial and aortic aneurysms in Behcet's syndrome: a case report.

Clin Rheumatol. 2008 Feb;27(2):265-7. doi: 10.1007/s10067-007-0713-z. Epub 2007 Oct 11.

Baricitinib for the treatment of refractory vascular Behçet's disease.

Clin Immunol. 2023 May;250:109298. doi: 10.1016/j.clim.2023.109298. Epub 2023 Mar 24.

引用本文的文献

Rise of biologics in noninfectious uveitis: a retrospective cohort study from Nepal.

Ann Med Surg (Lond). 2023 Apr 11;85(5):1486-1489. doi: 10.1097/MS9.0000000000000546. eCollection 2023 May.

Recent Insights into the Management of Behçet Syndrome.

J Inflamm Res. 2021 Jul 20;14:3429-3441. doi: 10.2147/JIR.S285400. eCollection 2021.

Response to: 'Correspondence on 'A pilot study of tofacitinib for refractory Behçet's syndrome'' by Zou .

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Response to: 'Correspondence on 'A pilot study of tofacitinib for refractory Behçet's syndrome'' by Zou .

作者信息

机构信息

出版信息

相似文献

引用本文的文献